Clinical trial

Tumor Nutritional Therapy in the First-line Treatment of Stage IV NSCLC

NCT06356701

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2024-04-15

PhasePHASE1

Study timeline

Study start (estimated)2024-04-15Date precision: day

Registry last updated2024-04-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Long-Term Effects Secondary to Cancer Therapyunresolved

Interventions

Cancer nutritional treatment regimen (Spirulina Bifidobacterium Capsules, Fish Oil Grape Seed Blueberry Soft Capsules, Ganoderma Spore Oil Soft Capsules)DIETARY_SUPPLEMENT

Sponsors & collaborators

The First Affiliated Hospital of Dalian Medical Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06356701 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.